Leadership Team

The Leadership Team at Vibliome Therapeutics drives the strategic vision and operational excellence of the company. Comprising the Co-founder, CEO, and VP of Medicinal Chemistry, the team oversees the development of innovative small molecule kinase inhibitors, ensuring alignment between research initiatives and business objectives to enhance drug discovery and foster growth in the therapeutic landscape.